MétaCan
Menu
Back to cohort
Record W2266877858

Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.

2007· article· en· W2266877858 on OpenAlexaff
Fabio Pastorino, Davis Mumbengegwi, Doménico Ribatti, Theresa M. Allen, Mirco Ponzoni

Bibliographic record

VenueMolecular Cancer Therapeutics · 2007
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA Interference and Gene Delivery
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsPropidium iodideMelanomaIn vivoDoxorubicinIn vitroApoptosisCancer researchAnnexinPharmacologyMTT assayMedicineChemistryChemotherapyMolecular biologyBiologyProgrammed cell deathBiochemistryInternal medicine
DOInot available

Abstract

fetched live from OpenAlex

C106 Patients with advanced or metastatic melanoma have a very poor prognosis, due to the resistance of melanoma cells to conventional chemotherapy. We previously reported that coated cationic liposomes (CCL) targeted with a monoclonal antibody against the disialoganglioside GD2 and containing c-myc antisense oligodeoxynucleotides (αGD2-CCL[c-myc-as]) resulted in selective inhibition of the proliferation of GD2-positive melanoma cells in vitro, while inducing apoptosis and partial tumor growth arrest in melanoma xenografts. Our aim in this work was to define the role of c-myc-asODN treatment in the susceptibility to doxorubicin (DXR) in human melanoma cells, both in vitro and in vivo.
 To determine chemosensitization of melanoma cells to DXR by c-myc antisense oligodeoxynucleotides (asODNs), human melanoma cells were incubated for 2 h with αGD2-CCL[c-myc-as] (10 μM asODN concentration). After washing, cells were then incubated with DXR (concentrations ranging from 0.061 μg/ml DXR to 250 μg/ml) and the inhibition of cell proliferation determined after 48 hours by the MTT assay. Annexin V-FITC and propidium iodide (PI) double staining were used to detect apoptotic and necrotic cells after treatments. For in vivo experiments, athymic mice were injected subcutaneously with the human melanoma cell, MZ2-MELand intravenously treated, every day for 3 days, with 3.5mg ODN/kg of αGD2-CCL[c-myc-as], untargeted liposomal DXR (SL[DXR]) or αGD2-targeted liposomal DXR (αGD2-SIL[DXR]) at 2 mg DXR/kg, or with a combination of the ODN and DXR formulations. Histological evaluation of cryopreserved tumor tissues was performed at 7 and 14 d from the end of treatment, using mAbs against the Ki-67 proliferation antigen, the endothelial marker CD31 and TUNEL for detecting apoptosis.
 In vitro cytotoxicity studies revealed that growth of melanoma cells was inhibited to a greater extent by αGD2-CCL[c-myc-as] than by the corresponding untargeted formulations or by free c-myc-as. Targeted c-myc-as sensitized cells to DXR, reducing the IC50 by approximately 10-fold. Scrambled ODNs had no effect on the IC50 of DXR. Compared to either treatment alone, combination of targeted c-myc-as and DXR resulted in earlier apoptosis and necrosis after 2 days of treatment. In vivo experiments revealed that liposomal formulations of c-myc-as and DXR, both targeted via GD2, led to the most pronounced delay in tumor growth when administered in a sequential manner. As a result, their combination translates into a statistically significant suppression of blood vessel density and an enhanced apoptosis, compared to all treatments given separately.
 Our data indicate the increasing cell sensitivity to DXR by targeted c-myc-asODNs as a promising basis for developing novel anti-tumor strategy against advanced melanoma.
 F.P. is a recipient of a Fondazione Italiana per la Lotta al Neuroblastoma fellowship.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.022
Threshold uncertainty score0.596

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.251
Teacher spread0.244 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2007
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicRNA Interference and Gene DeliveryFrench-language works237,207